Koji Oba

Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial

Satoshi Ebata, Ayumi Yoshizaki, Koji Oba et al. · The Lancet Rheumatology · 2021 · 238 citations

Systemic Scleroderma, Systemic Treatment, Immunology +6

Effects of Candesartan Compared With Amlodipine in Hypertensive Patients With High Cardiovascular Risks

Toshio Ogihara, Kazuwa Nakao, Tsuguya Fukui et al. · Hypertension · 2008 · 236 citations · Full text

Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer

Toshiaki Watanabe, Yoichi Ajioka, Keiichi Mitsuyama et al. · Gastroenterology · 2016 · 194 citations · Full text

The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis

Takashi Kurita, Shinsuke Yasuda, Koji Oba et al. · Lara D. Veeken · 2014 · 143 citations · Full text

Vasoactive-inotropic score as a predictor of morbidity and mortality in adults after cardiac surgery with cardiopulmonary bypass

Yumiko Yamazaki, Koji Oba, Yoshiro Matsui et al. · Journal of Anesthesia · 2018 · 135 citations

Cardiac Surgery, Adult Cardiac Surgery, Cardiac Anaesthesia +10